F.D.A. faulted for problems with drug tracking -

January 14, 2016. New York Times. Federal investigators said Thursday that there were flaws in the way the Food and Drug Administration tracked drugs after they came to market, raising questions about the agency’s effectiveness as the country’s main drug overseer.

FDA faulted for failure to track safety issues with drugs already on market -

January 14, 2016, Stat. Most Americans assume that drugs approved by the Food and Drug Administration are safe to take as directed. But safety concerns often arise only after the drugs go on the market, when companies or doctors tell the FDA about cases of patients who have fallen ill or died from their medications.

Politicians want to speed up drug approvals. That could backfire. -

November 24, 2015 To patients grappling with incurable diseases, new therapies can’t come quickly enough. But a pair of new studies found that speeding up this process could put Alzheimer’s, Parkinson’s, and depression drugs that are ineffective or harmful on the market..